On 25 December, Chugai Pharmaceutical Co. Ltd. announced an agreement with Taizhou Medical High-Tech Industrial Development Zone (China Medical City) to establish an import and sales and marketing subsidiary in China. The subsidiary, named Chugai Pharma (China) Co.

Ltd, is set to be established from March 2014 in the city of Taizhou, Jiangsu province, with capital of USD 30 million. The unit will be responsible for conducting importing, and sales and marketing activities related to Chugai's products in China. It will take responsibility for the distribution of its products, increasing the flexibility of its operations.